Skip to main content
. Author manuscript; available in PMC: 2015 Feb 20.
Published in final edited form as: Growth Factors. 2014 Nov 19;32(6):214–222. doi: 10.3109/08977194.2014.983225

Figure 5.

Figure 5

Block and let die: exogenous administration of anti-EphA2 scFv antibody reduces cell proliferation and induces apoptosis in lymphoma cell lines. (A) Apoptosis analysis in Raji, Ly19 and Toledo lymphoma cell lines treated for 24 h with 1 μg/ml or 5 μg/ml of D2 scFv. (B) Cell proliferation analysis was performed every 24 h in Raji lymphoma cell line treated with vehicle as control or 1 μg/ml, 5 μg/ml or 10 μg/ml of D2 scFv.